Cargando…

GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer

Inflammation is frequently associated with initiation, progression, and metastasis of colorectal cancer (CRC). Here, we unveil a CRC-specific metastatic programme that is triggered via the transcriptional repressor, GFI1. Using data from a large cohort of clinical samples including inflammatory bowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Wenjing, Xiao, Yun, Lu, Xinliang, Zhu, Hongyan, He, Xiangchuan, Huang, Wei, Lopez, Elsa S, Wong, Jerry, Ju, Huanyu, Tian, Linlu, Zhang, Fengmin, Xu, Hongwei, Wang, Sheng Dian, Li, Xia, Karin, Michael, Ren, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423119/
https://www.ncbi.nlm.nih.gov/pubmed/28387757
http://dx.doi.org/10.1038/cdd.2017.50
Descripción
Sumario:Inflammation is frequently associated with initiation, progression, and metastasis of colorectal cancer (CRC). Here, we unveil a CRC-specific metastatic programme that is triggered via the transcriptional repressor, GFI1. Using data from a large cohort of clinical samples including inflammatory bowel disease and CRC, and a cellular model of CRC progression mediated by cross-talk between the cancer cell and the inflammatory microenvironment, we identified GFI1 as a gating regulator responsible for a constitutively activated signalling circuit that renders CRC cells competent for metastatic spread. Further analysis of mouse models with metastatic CRC and human clinical specimens reinforced the influence of GFI1 downregulation in promoting CRC metastatic spread. The novel role of GFI1 is uncovered for the first time in a human solid tumour such as CRC. Our results imply that GFI1 is a potential therapeutic target for interfering with inflammation-induced CRC progression and spread.